Protai
Protai

Protai

AI-driven platform for protein-level disease mapping and drug discovery.

2021Active28Tel Aviv, Israel

About

Protai has developed an end-to-end AI-based platform designed to comprehensively map the progression of diseases at the protein level. This enhances the observation of cellular functions and aims to revolutionize the drug discovery process.

Key facts

At-a-glance profile data

Website
protai.bio
Headquarters
Tel Aviv, Israel
Founded
2021
Employees
28
Total funding
$20M (Seed)
Business model
B2B

Funding rounds

Funding rounds raised by Protai
DateRoundAmountLead investors
15 Mar 2023Seed$12M-
5 Jan 2022Seed$8M-

Tech stack

Detected on protai.bio, last scanned 13 Sept 2026. Run your own scan

CMS / Builders
Lovable
CDN
Cloudflare
Email provider
Google Workspace
Add first review

Frequently asked

How much funding has Protai raised?

Protai has raised a total of $20M in funding. The most recent round on record is Seed.

How many employees does Protai have?

Protai has approximately 28 people on record.